Hepatitis: all 3,372 studies
Page 24 of 34. Open to participants first (195), then studies with results posted, then the rest; newest registration first within each.
- Liver Transplantation in Alcoholic HepatitisSuspendedNCT01768715
- Prophylactic Use of Entecavir for HBsAg Positive Lymphoma Patients Treated With Rituximab-based ImmunochemotherapyStatus unknownNCT01768195Phase 4
- Altered Drug Disposition and Biomarkers for Diagnosis of Chronic Inflammatory Liver DiseaseCompletedNCT01766960Phase 1
- Long-term Follow Up of Viral Hepatitis in Uremic Patients in TaiwanStatus unknownNCT01766895
- Hepatitis C Virus Post-Exposure Prophylaxis for Health Care WorkersWithdrawnNCT01766115Phase 4
- Prophylactic Use of Entecavir for HBsAg Negative/HBcAb Positive/Hepatitis B Virus DNA Negative Patients With LymphomaStatus unknownNCT01765231Phase 4
- Patterns of Early Hepatitis C Virus Decline Predict the Outcome of Interferon Therapy (sIFN-pred2)Status unknownNCT01760148
- Efficacy and Safety of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis BCompletedNCT01760122Phase 3
- Predictors of Response to Combined Pegylated Interferon and Ribavirin in Chronic Hepatitis C Infected Egyptian PatientsStatus unknownNCT01758939
- Safety and Efficacy Study of Peginterferon Lambda-1a vs. Peginterferon Alfa-2a, Plus Ribavirin in Subjects With Genotype 1 Hepatitis CCompletedNCT01754974Phase 3
- Acupuncture as an Adjunctive Treatment for Hepatitis C PatientsStatus unknownNCT01750515Not applicable
- An Observational Study of Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) on Predictive Values of RVR on Sustained Virological Response in Different Stages of Liver Fibrosis in Treatment-Naïve Patients With Chronic Hepatitis C Genotype 1CompletedNCT01750216
- A Study of Ritonavir-Boosted Danoprevir in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients of Asian Origin With Chronic Hepatitis C Genotype 1 With or Without CirrhosisCompletedNCT01749150Phase 2
- Study of Telbivudine and Lamivudine to Prevent Vertical Transmission of Hepatitis BCompletedNCT01743079Phase 4
- An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Positive or HBeAg-Negative Chronic Hepatitis BCompletedNCT01734018
- TDF VS LAM + ADV in LAM + ADV Treated LAM-resistant CHB Patients With Undetectable Hepatitis B Virus DNACompletedNCT01732367Phase 4
- Study for Consolidation Period of Chronic Hepatitis BCompletedNCT01732354
- To Compare the Efficacy of Combined Tenofovir Plus Telbivudine vs Tenofovir Alone in Patients With Spontaneous Reactivation of Hepatitis BCompletedNCT01732224Not applicable
- "Real-life" Cohort of Patients With Chronic Hepatitis B Virus InfectionStatus unknownNCT01732081
- A Pilot Study to Treat Patients With Chronic Hepatitis C Virus (HCV) Genotype 1 and End-Stage Renal Disease (ESRD)Status unknownNCT01731301Phase 4
- An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis BCompletedNCT01730508
- Application of the Stem Cell Therapy in the End Stage Liver Disease and Assessment Its Consequences in the Quality of Live Style as Well as Development of HCC.Status unknownNCT01729221
- Tenofovir in Asian Chronic Hepatitis B PatientsCompletedNCT01728935Not applicable
- Miravirsen Study in Null Responder to Pegylated Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis CStatus unknownNCT01727934Phase 2
- A Study to Compare Efficacy and Safety of Tenofovir Used Alone or in Combination With Pegylated Interferon Alpha-2b in Participants With Chronic Hepatitis B and Elevated Alanine Aminotransferase (MK-4031-384)WithdrawnNCT01727271Phase 4
- A Phase 2 Study to Evaluate the Safety and Efficacy of VX-135 With Ribavirin in Treatment-Naïve Subjects With Chronic Hepatitis CCompletedNCT01726946Phase 2
- Effectiveness of Nucleos(t)Ide Analogs (NUC) Therapy Among Naive CHB Patients in ChinaCompletedNCT01726439
- In Hepatitis C Patients Treated With Interferon and Ribavirin, Does Hepcidin Contribute to Treatment Induced AnaemiaCompletedNCT01726400
- Using Entecavir to Reduce Hepatitis in Highly Viremic HBV Patients During Anti-tuberculous TreatmentStatus unknownNCT01724723Phase 4
- A Study to Evaluate the Safety, Tolerability, and Effectiveness of a 12-Week Combination Therapy of TMC647055 and TMC435 With and Without GSK23336805 With a Pharmacokinetic Enhancer With and Without Ribavirin in Patients Infected With Chronic Genotype 1 Hepatitis C VirusCompletedNCT01724086Phase 2
- 3-Year Observational Virology Follow-up Study in Subjects Who Participated in Studies of Idenix Anti-HCV, Direct Acting AntiviralsTerminatedNCT01721265
- Efficacy and Safety Evaluation of a Regimen Consisting of Peginterferon Lambda-1a + Ribavirin + Daclatasvir (Lambda + RBV + DCV) in HCV Genotype 1b Treatment naïve Patients or Prior Relapsers to Peginterferon Alfa + Ribavirin (Alfa + RBV) TherapyCompletedNCT01718158Phase 3
- A Phase 3, Comparative Study of Asunaprevir and Daclatasvir Combination Therapy Versus Telaprevir Therapy in Japanese HCV SubjectsCompletedNCT01718145Phase 3
- Hepatitis C Treatment in Underserved PopulationsStatus unknownNCT01717560Not applicable
- Telaprevir Exposure and Severe Anemia in HCV Infected Patients Treated by Tri-therapyTerminatedNCT01716403
- Tenofovir Disoproxil Fumarate vs. Entecavir in Chronic Hepatitis B Patients With Partial Virologic Response to EntecavirCompletedNCT01711567Phase 4
- The Role of FGL2-FcgammaRIIB Inhibitory Pathway in Human Viral HepatitisCompletedNCT01711164
- Pharmacokinetic Study of BMS-914143 in Participants With Normal Renal Function and Mild, Moderate, Severe and End-stage Renal DysfunctionCompletedNCT01708889Phase 1
- The Impact of Everolimus Based Immunosuppression in the Evolution of Hepatitis C Fibrosis After Liver TransplantationCompletedNCT01707849Phase 3
- A Retrospective Biomarker Study of Stored Samples Obtained From Patients With Chronic Hepatitis BCompletedNCT01705704
- Study of a Novel Therapeutic Vaccine Against Hepatitis C Using Ad6NSmut and MVA-NSmut in Chronically Infected PatientsCompletedNCT01701336Phase 1
- A Trial of Ribavirin in Patients With ACLF Due to Hepatitis E VirusStatus unknownNCT01698723Phase 2
- Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFαTerminatedNCT01694264Phase 3
- SIMpill Medication Dispensing Device in the Treatment of HCVWithdrawnNCT01691235
- Molecular Adsorbent Recirculating System (MARS®) in Hypoxic HepatitisStatus unknownNCT01690845Phase 2
- Randomized Controlled Open Label Trial of Peg Alpha 2a Interferon and Adjusted-dose of Ribavirin vs. Standard Therapy in the Treatment of Naive Chronic Hepatitis C Patients Infected With Genotype 4CompletedNCT01686789Phase 4
- Study to Evaluate the Treatment for Chronic Hepatitis C With Normal Transaminases in HIV Positive PatientsCompletedNCT01684787Phase 4
- Improving Blood Safety and HIV Testing in BrazilCompletedNCT01681420Not applicable
- An Observational Study of Pegasys in Dual- or Triple-Therapy in Patients With Chronic Hepatitis CCompletedNCT01679834
- Prospective Study In Noninvasive Evaluation of Hepatic Fibrosis in Chronic Hepatitis BCompletedNCT01679769
- A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis BCompletedNCT01671787Phase 1
- An Observational Study To Assess Liver Fibrosis Stages in Patients With Chronic Hepatitis C InfectionCompletedNCT01671046
- Umbilical Cord Mesenchymal Stem Cells for Patients With Autoimmune HepatitisStatus unknownNCT01661842Phase 1/2
- Vitamin D as an add-on Therapy With Pegylated Interferon and Ribavirin for Chronic Hepatitis cStatus unknownNCT01655966Phase 3
- Effect of High-protein High-fiber Diet in Patients With Autoimmune HepatitisCompletedNCT01655121Not applicable
- Impact of an Antibiotic (Rifaximin) on Liver Scarring in HIV-Infected Patients With Liver DiseaseWithdrawnNCT01654939Phase 4
- Boceprevir With Peginterferon Alfa-2b and Ribavirin in the Treatment-naive Patients Infected With Genotype 4 Chronic Hepatitis C InfectionStatus unknownNCT01653236Phase 3
- Study in HCV-Infected Patients to Determine the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of JNJ-47910382TerminatedNCT01651767Phase 1
- Hansenula-derived Pegylated Interferon in Treatment of Patients With Chronic Hepatitis CStatus unknownNCT01649245Phase 4
- Reducing Hepatitis C Virus (HCV)/Human Immunodeficient Virus (HIV) Risk Behaviors Among Injection Drug Users in ChinaCompletedNCT01647191Not applicable
- Drug Interaction Study to Assess the Effect of Co-Administered Miravirsen and Telaprevir in Healthy SubjectsCompletedNCT01646489Phase 1
- A Follow-Up Study of Patients With HBeAg Positive Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML22265CompletedNCT01645969
- Computer-based Cognitive Behavioral Therapy for Risky Behaviors in Opioid Dependent PatientsCompletedNCT01645033Not applicable
- Prevalence of Hepatitis B Infection in the Galilee Region, IsraelWithdrawnNCT01645007
- Safety and Tolerability of Boceprevir in Combination With Peginterferon Alfa-2b Plus Ribavirin for the Treatment of Vietnamese Subjects With Chronic Hepatitis C Genotype 1 (P08599)WithdrawnNCT01641666Phase 3
- Tolerability, Immunogenicity and Efficacy of HB-110 Administered by Electroporation in Chronic Hepatitis B PatientsCompletedNCT01641536Phase 1
- Identification of Specific Modulation Frequencies in Hepatitis B Carriers With and Without Hepatocellular CarcinomaCompletedNCT01641276Not applicable
- Effect of Teleprevir in Triple Therapy on Intrahepatic Immunological MechanismsCompletedNCT01641094
- Sustained Virological Response (SVR)Rate of Pegasys Plus Ribavirin in Patients With Chronic Hepatitis CTerminatedNCT01639547Not applicable
- Tenofovir vs. Tenofovir Plus Entecavir in Entecavir-Resistant Chronic Hepatitis BCompletedNCT01639092Phase 4
- Tenofovir Plus Entecavir vs. Tenofovir in Adefovir-Resistant Chronic Hepatitis BCompletedNCT01639066Phase 4
- Histologic Changes and Noninvasive Assessment in Hepatitis C Patients Treated with Peginterferon Alpha-2a and RibavirinCompletedNCT01634919
- ST-2; a Non-invasive Fibrosis Marker for Chronic Hepatitis BStatus unknownNCT01633554
- Phase 2b Study of BMS-986094 and Daclatasvir, With or Without Ribavirin for the Treatment of Patients With Chronic Hepatitis CWithdrawnNCT01629732Phase 2
- ANNAPURNA: A Study of The Combination of RO5466731, RO5190591, Ritonavir and Copegus (Ribavirin) With or Without RO5024048 in Patients With Chronic Hepatitis C Who Are Either Treatment-Naïve or Have Previously Experienced a Null Response to Interferon-Based TreatmentCompletedNCT01628094Phase 2
- Efficacy of Short-term Immunosuppressive Therapy and Anti-allergenic Therapy in Severe Acute Exacerbation of Chronic Hepatitis BStatus unknownNCT01627236Not applicable
- Comparison Between Lamivudine and Entecavir Treatment in Spontaneous Severe Acute ExacerbationTerminatedNCT01627223Phase 4
- Inflammation, Stress & Social Behavior: Using Ecological Assessments & Model Systems to Enhance Relevance to Health OutcomesWithdrawnNCT01625793Not applicable
- Optimization of Antiviral Therapy of Chronic HBV InfectionCompletedNCT01623778
- BIP48 (Peginterferon Alfa 2b 48kDa) Compared With Pegasys® (Peginterferon 2a 40kDa) for Treatment of Chronic Hepatitis CStatus unknownNCT01623336Phase 2/3
- Safety and Efficacy Study of Pegylated Interferon Lambda With and Without Daclatasvir, Compared to Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C Genotype 2 and 3CompletedNCT01616524Phase 3
- HBV DNA Levels During Pregnancy in Chronic Hepatitis BStatus unknownNCT01610115
- An Observational Study of Peginterferon Alfa-2a in Combination With Ribavirin in Participants With Chronic Hepatitis C and Compensated Liver CirrhosisCompletedNCT01609049
- A Phase III Study of BI201335 in Treatment-naive and Prior Relapser Patients With Chronic Hepatitis C InfectionWithdrawnNCT01608737Phase 3
- Pharmacogenomics Study on IL28B Genetic Variants in Chinese Children With Hepatitis C Virus InfectionStatus unknownNCT01607021
- Rifaximin to Prevent Recurrent HCV-Related Fibrosis After Liver TransplantStatus unknownNCT01603108Phase 2
- Efficacy of Peg-interferon α-2a in Hepatitis B Patients Treated by Entecavir Without HBeAg LossStatus unknownNCT01599130Not applicable
- Antiviral Efficacy of Switching to ETV Plus TDFStatus unknownNCT01597934Phase 4
- Efficacy and Effectiveness of PegInterferon and Ribavirin in Korean Patients With Chronic Hepatitis CCompletedNCT01596517Phase 4
- Telbivudine Versus Entecavir in Reducing Serum HBsAg Levels in Patients With HBeAg-positive Chronic Hepatitis BCompletedNCT01595685Phase 3
- Switch From Adefovir to Tenofovir in Chronic Hepatitis B for Suboptimal Response to Adefovir-based Combination TherapyStatus unknownNCT01595633Phase 4
- Entecavir Plus Tenofovir Combination in Subjects With Multi-drug Resistant Chronic Hepatitis B Virus InfectionStatus unknownNCT01594905Phase 4
- A Multiple Dose Study to Evaluate the Safety and Efficacy of MK-2748 in Hepatitis C-Infected Participants (MK-2748-002 AM1)CompletedNCT01593735Phase 1
- A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis CCompletedNCT01591668Phase 1
- A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus InfectionCompletedNCT01590654Phase 1
- A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis BCompletedNCT01590641Phase 1
- Registry Study for Patients With Chronic HBV Receiving Nucleotide TherapyCompletedNCT01590615
- First in Human Study of ALS-002200; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1CompletedNCT01590407Phase 1
- Assessment of HBV Vaccine Immunity After 18 YearsStatus unknownNCT01590381
- Efficacy and Safety of Boceprevir in Combination With Peginterferon Alfa-2b Plus Ribavirin in Pediatric Subjects With Chronic Hepatitis C Genotype 1 (P08034)WithdrawnNCT01590225Phase 3